Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
Vaccination update March 2023 – Shingles Vaccination
Vaccination Update March 2023: Shingles If you are aged 70 or older you may be invited to have the Shingles vaccine. Please note: The shingles vaccine does not help a person who already has shingles or post-herpetic neuralgia*. You cannot get shingles from someone...
Vaccination Update March 2023 – Pneumonia Jab
Vaccination Update March 2023: “Pneumonia Jab” Infections, such as pneumonia, can seriously impact on the symptoms experienced, quality of life and overall health of all patients with Neuroendocrine Cancer - particularly those with DIPNECH and/or a Lung Primary, those...
Kate Quirk – INCA Research Committee
Kate Quirk, Neuroendocrine Cancer UK Patient Support Coordinator, has just been appointed to the INCA Research Committee, after contributing to the completion of a project to bring wider access to Clinical Trials for Neuroendocrine Cancer patients globally. INCA (the...